ODDB.org: Open Drug Database

Sanofi-Aventis (Suisse) SA - Kevzara 200 mg/1.14 ml, solution pour injection en stylo pré-rempli

Swissmedic Registration	66425	Sequence	02
Product name	Kevzara 200 mg/1.14 ml	Description	solution pour injection en stylo pré-rempli
ATC-Classification	L04AC14	ATC-Description	Sarilumab
Introduction of Sequence	20.04.2018

Composition

sarilumabum 200 mg, histidinum aut histidini hydrochloridum monohydricum, arginini hydrochloridum, saccharum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 1.14 ml.

Packungsbestandteile

Galenic Form

solution pour injection en stylo pré-rempli

Excipiens

Active Agent	Dose
Sarilumabum	200mg / 1.14ml

BAG: Active Agent	Dose
Sarilumabum	200 mg

Inactive agents
Arginine Hydrochloride
Histidinum aut Histidini Hydrochloridum Monohydricum
Polysorbatum 20
Saccharum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
003	2	959.37	1059.80	B	SL	Yes

2025	©ywesee GmbH